Grifols S.A. revenue for the last year amounted to 6.59 B EUR, the most of which — 5.56 B EUR — came from its highest performing source at the moment, Biopharma, the year earlier bringing 5.01 B EUR. The greatest contribution to the revenue figure was made by United States and Canada — last year it brought Grifols S.A. 3.90 B EUR, and the year before that — 3.86 B EUR.